Switzerland has rejected the AstraZeneca Oxford COVID-19 vaccine due to lack of sufficient data.
Switzerland Rejects AstraZeneca Oxford COVID-19 Vaccine Due To Lack Of Sufficient Data
Swissmedic, Switzerland's authority for medicines and medical devices, said it cannot authorise the jab as data submitted "are not yet sufficient".
In a statement, the body said following an "extraordinary" meeting on February 2, its Human Medicines Expert Committee (HMEC) confirmed their assessment.
They said they could award approval once additional data from Phase III trials in America arrived.
But they added this would only be "temporary" according to their procedure.
Part of the statement read:
"The data currently available do not point to a positive decision regarding benefits and risks.
"To obtain a conclusive assessment, the applicant will among other things have t...